INOVIO PHARMACEUTICALS, INC. Effective Income Tax Rate Reconciliation, Tax Contingency, Amount
INOVIO PHARMACEUTICALS, INC. (INO) reported Effective Income Tax Rate Reconciliation, Tax Contingency, Amount of $1.50 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationTaxContingencies · last filed 2026-03-12
- INOVIO PHARMACEUTICALS, INC. effective income tax rate reconciliation, tax contingency, amount for fiscal 2025 was $1.50M, a 35.79% decline from fiscal 2024.
- INOVIO PHARMACEUTICALS, INC. effective income tax rate reconciliation, tax contingency, amount for fiscal 2024 was $2.34M, a 172.24% increase from fiscal 2023.
- INOVIO PHARMACEUTICALS, INC. effective income tax rate reconciliation, tax contingency, amount for fiscal 2023 was $861.00K, a 62.42% decline from fiscal 2022.
- INOVIO PHARMACEUTICALS, INC. effective income tax rate reconciliation, tax contingency, amount for fiscal 2022 was $2.29M, a 64.80% decline from fiscal 2021.
| Period end | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount 12 month |
|---|---|
| 2025-12-31 | $1.50M 10-K · filed 2026-03-12 |
| 2024-12-31 | $2.34M 10-K · filed 2026-03-12 |
| 2023-12-31 | $861.00K 10-K · filed 2025-03-18 |
| 2022-12-31 | $2.29M 10-K · filed 2024-03-06 |
| 2021-12-31 | $6.51M 10-K · filed 2024-03-06 |
| 2020-12-31 | $1.07M 10-K · filed 2023-03-01 |
| 2019-12-31 | $1.54M 10-K · filed 2022-03-01 |
| 2018-12-31 | $1.27M 10-K · filed 2021-03-01 |
| 2017-12-31 | $846.00K 10-K · filed 2020-03-12 |
| 2016-12-31 | $1.37M 10-K · filed 2019-03-12 |
| 2015-12-31 | $1.97M 10-K · filed 2018-03-14 |
| 2014-12-31 | $340.00K 10-K · filed 2017-03-15 |
| 2013-12-31 | $495.00K 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |